Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1626 results

Cerebral protection devices

19 Nov 2023 – From PCR London Valves 2023

Consult the slides on this page to analyze the use of a latest-generation cerebral protection device, observe a transcatheter mitral valve-in-valve performed with cerebral protection in a TAVR case, or appreciate the value of cerebral protection in an anomalous aortic arch.

Cerebral protection devices

TAVI in cardiogenic shock

19 Nov 2023 – From PCR London Valves 2023

Because TAVI implantation, a routine procedure, is not always a breeze, look at a number of challenging cases, including a case of aortic stenosis complicated by cardiogenic shock, an emergency valve-in-valve TAVI, or a TAVI for left ventricular assist device.

TAVI in cardiogenic shock

The mortality burden of untreated aortic stenosis

14 Nov 2023

This study, based on extensive real-world data, aimed to assess mortality rates across different untreated AS severities and AS treatment rates.

Alessandro Sticchi

Reviewer

Alessandro Sticchi

Reviewer

Giulia Costa
The mortality burden of untreated aortic stenosis

Cerebral embolic protection during TAVI: evidence meets practice

11 Nov 2023

Watch the replay of this webinar with D. Mylotte, C. Cook and R. Kharbanda to know more about the incidence and impact of TAVI associated stroke and much more!

Cerebral embolic protection during TAVI: evidence meets practice

Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis and small aortic annuli: A randomized clinical trial (the VIVA Trial)

27 Oct 2023

Luis Ortega-Paz interviews Josep Rodés-Cabau on the results of the VIVA trial which he presented at TCT Congress 2023 in San Francisco.

Luis Ortega-Paz

Author

Luis Ortega-Paz
Josep Rodés-Cabau

Author

Josep Rodés-Cabau
Transcatheter versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

Four-Year Outcomes from the EVOLUT Low Risk Trial

26 Oct 2023

Dejan Milasinovic provides his take on the EVOLUT Low Risk trial, presented by Michael I. Reardon at TCT Congress 2023. 4-year results reveal a continuing trend towards lower combined rates of all-cause mortality and disabling stroke with TAVI compared with surgical aortic valve replacement (SAVR)

Dejan Milasinovic

Author

Dejan Milasinovic
Four-Year Outcomes from the EVOLUT Low Risk Trial

Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation – The WATCH-TAVR Trial

26 Oct 2023

Panos Xaplanteris provides his take on WATCH-TAVR results which were presented by Samir R. Kapadia at TCT Congress 2023.

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial

Five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial

26 Oct 2023

Alex Sticchi provides his take on the 5-year outcomes from PARTNER 3 Low Risk which were presented by Martin B. Leon at TCT Congress 2023.

Alessandro Sticchi

Author

Alessandro Sticchi
Five-Year Clinical and Echocardiographic Outcomes from The PARTNER 3 Low-Risk Randomized Trial

The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial

25 Oct 2023

Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...

Nicola Ryan

Author

Nicola Ryan
Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement System in High-Risk Patients with Symptomatic Severe Native Aortic Regurgitation (ALIGN-AR)

Inner curvature technique for the implantation of a balloon-expandable valve

24 Oct 2023

Find out more about this technique that allows smooth and controlled navigation across the aortic arch along the inner curvature, facilitating the advancement and positioning of the delivery system, and avoiding unnecessary scraping of the aortic wall.

Won-Keun Kim

Author

Won-Keun Kim
Inner curvature technique for the implantation of a balloon-expandable valve

TAVI: from first valve to lifetime management

19 Oct 2023

Watch the replay of this webinar with T. Cuisset, O. De Backer and L. Rosseel to select the most appropriate TAV device for the index TAVI procedure and much more!

TAVI: from first valve to lifetime management

Severe symptomatic aortic stenosis in a "no access for TAVI" patient and an "unexpected" toll for balloon valvotomy

18 Oct 2023

An 88-year-old lady was admitted with resistant pulmonary oedema, a massively calcified aortic valve, renal failure and no transfemoral access option. How would you treat this patient?

Author

Haim Danenberg

Author

Lisa Manevich

Author

Dimitry Yakubovitch

Author

Adi Orbach
Severe symptomatic aortic stenosis in a 'no access for TAVI' patient and an 'unexpected' toll for balloon valvotomy

PCRonline @ TCT 2023 - Get the international perspective!

17 Oct 2023

Thanks to the contribution of our team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science to be released at TCT 2023 - check out the list here!

PCRonline @ TCT 2023 - get the international perspective!

Innovations in TAVI and mitral interventions

22 Sep 2023 – From AICT-AsiaPCR 2023

Discover the latest advancements in TAVI and mitral interventions in this session: discover strategies for managing non-operable cases involving triple vessel disease and severe mitral regurgitation, along with insights into tackling recurrent heart failure in patients with coronary artery and valvular heart disease, delve into the...

Innovations in TAVI and mitral interventions

Essentials of lifetime management in patient undergoing TAVI using novel balloon expandable Myval Octacor THV

22 Sep 2023 – From AICT-AsiaPCR 2023

This session with a LIVE case provides information about the Octacor transcatheter heart valve technology, highlighting its procedural and clinical benefits. It also covers the Octalign technique, which ensures precise alignment of commissural and coronary access, and discusses the precise sizing, positioning, and deployment of Octacor THV.

Essentials of lifetime

Percutaneous treatment of pure aortic regurgitation: a new indication

21 Sep 2023 – From AICT-AsiaPCR 2023

Analyse the case of an 83-year-old male patient with history of HT, parkinson's disease and minor stroke, who presented with worsening exertional SOB, LVEF 55-60 %, dilated LV, mild MR, and severe AR, and study the different options to treat aortic regurgitation.

Percutaneous treatment of pure aortic regurgitation: a new indication

Valve-in-valve - LIVE case

21 Sep 2023 – From AICT-AsiaPCR 2023

An 84-year-old man, with a history of 23 Carpentier-Edwards in 2004, PPM in 2013, AF on warfarin and impaired LV function (40 %), presented with severe symptomatic stenosis of the surgical bioprosthesis.

A 23 Navitor was implanted without predilatation and with post-dilatation under cerebral protection (Sentinel).

Closure was...

Valve-in-valve- AICT-AsiaPCR 2023

TAVI Insights: Addressing challenges and complex cases

21 Sep 2023 – From AICT-AsiaPCR 2023

In this session, explore the complexities of TAVR complications and learn about unique cases, including TAVI in patients with bicuspid aortic valves, coarctation of the aorta, and small annuli.

TAVI Insights: Addressing challenges and complex cases

Coronary, structural and peripheral interventions

21 Sep 2023 – From AICT-AsiaPCR 2023

Explore the latest innovations in coronary, structural, and peripheral interventions in this session, from machine learning CT-FFR systems for severe aortic stenosis to the role of real-world data in enhancing cardiovascular care, and discover cutting-edge techniques like transpedal accesses for complex lesions and comprehensive valve sizing...

Coronary, structural and peripheral interventions

Top abstracts of AICT-AsiaPCR 2023

21 Sep 2023 – From AICT-AsiaPCR 2023

Explore the cutting-edge research showcased in the top abstracts of AICT-AsiaPCR 2023, featuring insights on CT-based valve sizing for TAVR in bicuspid aortic stenosis and the impact of bleeding events post-TAVI on long-term mortality.

Top abstracts of AICT-AsiaPCR 2023